UPDATE : Monday, March 25, 2019
상단여백
US trade agency begins probe into Medytox’s complaint about Daewoong by Lee Han-soo 2019-03-04 11:16
Bridge Biotherapeutics to accelerate global presence by Lee Han-soo 2019-03-04 10:50
Doctors, medical students struggled for Korea’s independence from Japanese colonialists by Lee Han-soo 2019-03-01 07:36
GC starts P1 trials of hemophilia treatment by Lee Han-soo 2019-02-28 16:45
Bukwang to sell Novartis’ chronic hepatitis B treatment by Lee Han-soo 2019-02-28 14:59
라인
Korea to host annual Congress of Asian Society of Head and Neck Oncology by Lee Han-soo 2019-02-27 14:09
National Cancer Center finds mechanism of cancer progression in osteosarcoma by Lee Han-soo 2019-02-27 11:09
Roche Diagnostics gets reimbursement for ALK diagnostic method by Lee Han-soo 2019-02-27 11:09
‘Multi-department treatment increases survival rate of liver cancer’ by Lee Han-soo 2019-02-26 17:01
GC unveils P1 results for hepatitis B treatment by Lee Han-soo 2019-02-26 16:07
라인
‘Hardy kiwi extract can treat psoriasis’ by Lee Han-soo 2019-02-26 14:34
Daewon licenses in Tium Bio’s endometriosis drug candidate by Lee Han-soo 2019-02-26 13:58
CrystalGenomics’ US partner applies for P1 trial for leukemia treatment by Lee Han-soo 2019-02-26 11:29
Healcerion, Gil hospital develop world’s 1st 3-in-1 wireless ultrasound device by Lee Han-soo 2019-02-25 15:54
St. Mary’s Hospital uses 3D printing to correct deviated nasal septum by Lee Han-soo 2019-02-25 14:27
라인
Regulator OKs GC’s P3 trial of BCG vaccine by Lee Han-soo 2019-02-25 14:07
AMC succeeds in living donor liver transplant on US patient by Lee Han-soo 2019-02-25 14:07
Celltrion Healthcare posts ₩713.5 billion in 2018 sales by Lee Han-soo 2019-02-22 17:29
Alteogen applies for P1 trial for Eylea biosimilar by Lee Han-soo 2019-02-22 16:03
Regulator OKs Bukwang’s anticancer treatment by Lee Han-soo 2019-02-22 15:29
여백
여백
여백
Back to Top